Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Characterizing Disease Biology, Treatment Patterns and Toxicity in Older Adults With Advanced Hepatocellular Carcinoma
The University of Texas Health Science Center at San Antonio
84 participants
Sep 13, 2019
OBSERVATIONAL
Conditions
Summary
This is an observational, prospective cohort study that will recruit a diverse sample of 84 participants with newly diagnosed with unresectable, advanced hepatocellular carcinoma (HCC) at the UT Health Cancer Center in San Antonio. This study uses geriatric assessment tools with participants 65 years and older and collects adverse events and exploratory markers of aging for all participants.
Eligibility
Inclusion Criteria3
- Histologically or radiographically (CT or MRI) confirmed newly diagnosed hepatocellular carcinoma.
- Age 18 years and older.
- Patients with advanced, unresectable HCC as determined by the treating physician.
Exclusion Criteria2
- Patients with resectable HCC who are still candidates for locoregional therapy
- Patients receiving prior systemic or locoregional therapy
Interventions
Assessments will be done for participants that are 65 years or older.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03894917